Lyell Immunopharma, Inc. Common Stock (LYEL)
Since Aug 12, 2021, Lyell Immunopharma, Inc. Common Stock (LYEL) has reported earnings 21 times. On average the shares move ±5.06% post-earnings, with a positive reaction 71.4% of the time. Its largest post-earnings gain was +11.37% (Feb 28, 2023) and its largest decline was -18.13% (Nov 08, 2022). The next earnings report is predicted for 2026-11-10 (approximate).
Earnings reactions
How LYEL moved on each past earnings report.
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±5.06%
Positive %
71.4%
Negative %
28.6%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 06, 2026 | ☽ POST | +3.03% | open_in_new |
| May 06, 2026 | ☽ POST | -4.2% | open_in_new |
| Mar 12, 2026 | ☽ POST | -13.35% | open_in_new |
| Nov 12, 2025 | ☽ POST | +0% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±5.06%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260825 | open_in_new SEC.gov |
| 4 | 20260825 | open_in_new SEC.gov |
| 4 | 20260825 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260814 | open_in_new SEC.gov |
| 4 | 20260811 | open_in_new SEC.gov |
| 4 | 20260811 | open_in_new SEC.gov |
| 4 | 20260811 | open_in_new SEC.gov |
| 4 | 20260811 | open_in_new SEC.gov |
| 10-Q | 20260806 | open_in_new SEC.gov |
| 8-K | 20260806 | open_in_new SEC.gov |
Frequently asked about LYEL earnings
When does Lyell Immunopharma, Inc. Common Stock report earnings next? expand_more
Lyell Immunopharma, Inc. Common Stock (LYEL)'s next earnings date is approximate for 2026-11-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does LYEL stock move after earnings? expand_more
Over 21 reports, LYEL has moved an average of ±5.06% the session after earnings, closing higher 71.4% of the time.
What was LYEL's biggest post-earnings move? expand_more
LYEL's largest post-earnings gain on record was +11.37% on Feb 28, 2023, and its largest decline was -18.13% on Nov 08, 2022.
Where can I find Lyell Immunopharma, Inc. Common Stock's SEC filings? expand_more
All of Lyell Immunopharma, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right